Hologic Announces its Inclusion in the New NASDAQ Global Select Market

BEDFORD, Mass., Jun. 29, 2006 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX), a leading provider of state-of-the-art diagnostic and digital imaging systems directed towards women's health, today announced that it has been included in the new NASDAQ Global Select Market. The NASDAQ Global Select Market has the highest initial listing standards of any exchange in the world based on financial and liquidity requirements. Prior to the change, the company had been listed on the NASDAQ National Market.

"We are pleased NASDAQ has selected Hologic to join the NASDAQ Global Select Market," said Jack Cumming, Chairman and Chief Executive Officer. "It is a reflection of the hard work and dedication of everyone at this company. The company's solid financial performance over the last two years has exceeded expectations. We are proud of our success and look forward to a bright future with long-term growth. We believe our inclusion in this top tier is further validation of the opportunities that lie ahead for our company."

The new NASDAQ Global Select Market tier, which will become effective on July 3, includes approximately 1,200 companies of the approximately 3,200 companies listed by NASDAQ. In conjunction with the creation of the new tier, NASDAQ will rename the NASDAQ National Market the NASDAQ Global Market.

"Hologic is an example of an industry leader that has achieved superior listing standards, which clearly defines the essence of the NASDAQ Global Select Market," said Bruce Aust, Executive Vice President, Corporate Client Group. "NASDAQ is focused on leading a race to the top in terms of listing qualifications. In recognizing these companies, we are highlighting their achievement in meeting the requirements to be included in the market with the highest listing standards in the world."

NASDAQ announced the new three tier listing classification in February 2006. All three market tiers will maintain rigorous listing and corporate governance standards. For additional information about the NASDAQ Global Select Market, please go to:

About Hologic

Hologic Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on osteoporosis assessment, mammography and breast biopsy, and mini C-arm and extremity MRI imaging for orthopedic applications. For more information visit


NASDAQ is the largest U.S. electronic stock market. With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks. For more information about NASDAQ, visit or the NASDAQ Newsroom at

Forward Looking Disclaimer

This News Release contains forward-looking information that involves risks and uncertainties, including statements regarding the Company's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding the Company's anticipated long term growth and that inclusion in the Nasdaq Global Select Market is validation of future opportunities for the Company. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Risks and uncertainties that could cause actual results to materially differ include, without limitation, manufacturing risks that may limit the Company's ability to increase commercial production of the Selenia and other of the Company's digital products; uncertainties inherent in the development and enhancement of products; the risk that newly introduced products may contain undetected errors or defects or otherwise not perform as anticipated; the Company's ability to successfully manage current or future alliances or joint ventures; risks relating to proposed or completed acquisitions; the Company's ability to predict accurately the demand for its products, and products under development, and to develop strategies to address its markets successfully; the early stage of market development for digital X-ray products; expenses and uncertainties relating to litigation and governmental investigations; risks relating to compliance with financial covenants under the Company's leases; technical innovations that could render products marketed or under development by the Company obsolete; competition; and reimbursement policies for the use of the Company's products. The risks included above are not exhaustive. The annual reports on Form 10-K, the quarterly reports on Form 10-Q, current reports on Form 8-K and other documents the Company has filed with the SEC contain additional factors that could impact the Company's businesses and financial performance. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based.

  Glenn P. Muir                       Frances Crecco
  Executive Vice President & CFO      Director, Investor Relations
  Hologic, Inc.                       Hologic, Inc.
  (781) 999-7300                      (781) 999-7377

SOURCE: Hologic, Inc.

CONTACT: Glenn P. Muir, +1-781-999-7300, or Frances Crecco, +1-781-999-
7377, both of Hologic, Inc.

Web site: